EXPOSURE OF HEALTH-CARE WORKERS TO RIBAVIRIN DURING THERAPY FOR RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS

被引：23
作者：
BRADLEY, JS
CONNOR, JD
COMPOGIANNIS, LS
EIGER, LL
机构：
[1] CHILDRENS HOSP SAN DIEGO, SAN DIEGO, CA 92123 USA
[2] ZENITH INSURANCE CO, LOS ANGELES, CA 91365 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1990年 / 34卷 / 04期
关键词：
D O I：
10.1128/AAC.34.4.668
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Health care workers (HCW) are exposed to ribavirin aerosol during therapy of infants with respiratory syncytial virus infections. To asses the degree of HCW exposure, we analyzed air samples from patient rooms and HCW personal breathing zones during ribavirin aerosol delivery by ventilator (two samples), oxygen hood (two samples), and a new vacuum exhaust hood (four samples). HCW exposure to ribavirin during aerosol delivery by ventilator or vacuum exhaust hood system was substantially lower than HCW exposure during aerosol delivery by oxygen hood in rooms with adequate ventilation.
引用
收藏
页码：668 / 670
页数：3
相关论文
共 11 条
[1]   SENSITIVE RADIOIMMUNOASSAY FOR THE BROAD-SPECTRUM ANTIVIRAL AGENT RIBAVIRIN [J].
AUSTIN, RK ;
TREFTS, PE ;
HINTZ, M ;
CONNOR, JD ;
KAGNOFF, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :696-701
[2]   AEROSOLIZED RIBAVIRIN TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN INFANTS HOSPITALIZED DURING AN EPIDEMIC [J].
CONRAD, DA ;
CHRISTENSON, JC ;
WANER, JL ;
MARKS, MI .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (02) :152-158
[3]   RIBAVIRIN TREATMENT OF RESPIRATORY SYNCYTIAL VIRAL-INFECTION IN INFANTS WITH UNDERLYING CARDIOPULMONARY DISEASE [J].
HALL, CB ;
MCBRIDE, JT ;
GALA, CL ;
HILDRETH, SW ;
SCHNABEL, KC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (21) :3047-3051
[4]   AEROSOLIZED RIBAVIRIN TREATMENT OF INFANTS WITH RESPIRATORY SYNCYTIAL VIRAL-INFECTION - A RANDOMIZED DOUBLE-BLIND-STUDY [J].
HALL, CB ;
MCBRIDE, JT ;
WALSH, EE ;
BELL, DM ;
GALA, CL ;
HILDRETH, S ;
TENEYCK, LG ;
HALL, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1443-1447
[5]  
HARRISON R, 1988, MMWR-MORBID MORTAL W, V37, P560
[6]   CROSS-SPECIES EXTRAPOLATIONS AND THE BIOLOGIC BASIS FOR SAFETY FACTOR DETERMINATIONS IN DEVELOPMENTAL TOXICOLOGY [J].
JOHNSON, EM .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (01) :22-36
[7]   AEROSOLIZED RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH RESPIRATORY SYNCYTIAL VIRUS-DISEASE [J].
RODRIGUEZ, WJ ;
KIM, HW ;
BRANDT, CD ;
FINK, RJ ;
GETSON, PR ;
ARROBIO, J ;
MURPHY, TM ;
MCCARTHY, V ;
PARROTT, RH .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (02) :159-163
[8]   ENVIRONMENTAL EXPOSURE OF PRIMARY CARE PERSONNEL TO RIBAVIRIN AEROSOL WHEN SUPERVISING TREATMENT OF INFANTS WITH RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS [J].
RODRIGUEZ, WJ ;
BUI, RHD ;
CONNOR, JD ;
KIM, HW ;
BRANDT, CD ;
PARROTT, RH ;
BURCH, B ;
MACE, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1143-1146
[9]  
TABER LH, 1983, PEDIATRICS, V72, P613
[10]  
1986, FED REGISTER, V51, P34028
12